SEC Form 4 · accession 0001127602-18-009737
LEXICON PHARMACEUTICALS, INC. · LXRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey L Wade
Officer — EVP, Corp Adm Affairs and CFO
Period of report
Feb 28, 2018
Accepted (ET)
Mar 2, 2018 · 5:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 28, 2018 | M | 2,929 | — | A | 52,526 | D | |
| Common StockF1 | Feb 28, 2018 | M | 5,807 | — | A | 58,333 | D | |
| Common StockF1 | Feb 28, 2018 | M | 4,495 | — | A | 62,828 | D | |
| Common StockF1 | Feb 28, 2018 | M | 2,797 | — | A | 65,625 | D | |
| Common Stock | Feb 28, 2018 | F | 6,133 | $8.53 | D | 59,492 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F3 | — | Feb 28, 2018 | M | 2,929 | D | — | — | Common Stock | 2,929 | 0 | D |
| Restricted Stock UnitsF1,F4 | — | Feb 28, 2018 | M | 5,807 | D | — | — | Common Stock | 5,807 | 5,807 | D |
| Restricted Stock UnitsF1,F5 | — | Feb 28, 2018 | M | 4,495 | D | — | — | Common Stock | 4,495 | 8,990 | D |
| Restricted Stock UnitsF1,F6 | — | Feb 28, 2018 | M | 2,797 | D | — | — | Common Stock | 2,797 | 8,393 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of common stock.
- F2Withholding of a portion of vested shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- F3Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2015 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.
- F4Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.
- F5Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.
- F6Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.